Antibiotics

New guidance from the Infectious Diseases Society of America offers timely practice advice for the clinical treatment of three of the most common drug-resistant pathogens.

Soon after visiting 38 hospitals in Michigan, over half of patients hospitalized with suspected COVID-19 received antibiotics.

A University of Maryland Professor of Pathology explains that SARS-CoV-2 has unique ways of evading detection.

Robert H. Christenson, PhD, describes the threat of AMR and the role of relevant diagnostics in clinical settings.

The challenges of making formulary and clinical decisions based on regulatory studies are significant and the need for real-world clinical experience is increasingly important.

Dr. Pol Vandenbroucke describes the individual and collective risks associated with rising antibiotic resistance.

Dr. Pol Vandenbroucke talks about what makes antibiotic stewardship so important to clinicians and researchers.

Dr. Pol Vandenbroucke explains how the development of health and civil society infrastructure around the world helps to slow antimicrobial resistance.

Dr. Pol Vandenbroucke describes the alarming global threat of antimicrobial resistance.

Biopharmaceutical companies create nearly $1 billion fund to aid much needed pipeline for antimicrobial resistance.

Hospitalized patients with unverified penicillin allergies may unnecessarily face greater risk of adverse drug events when given broader spectrum alternative antibiotics, according to a new study.

Hollow-fiber infection model (HFIM) facilitates comparison of intermittent vs continuous infusion of ß-lactam antibiotic for K. pneumoniae

Despite guidelines discouraging use of anti-pseudomonal β-lactams and fluoroquinolones for community-acquired complicated intra-abdominal infection, about 75% of lower-risk patients are receiving such treatments, a new study found.

An overview of 3 recent infectious disease news stories.

Providing oral antibiotics to people who inject drugs with infections may reduce hospital readmissions.

Investigators from the Universitat Autònoma de Barcelona have identified links between antibiotic resistant S maltophilia phenotypes and "quorum sensing."

Early administration of such therapies in this patient group not shown to help mortality rates.

A review of 61 clinical trials suggests that acute uncomplicated cystitis in adult women could be treated with shorter duration of antibiotics in some cases.

Cefiderocol functions as a siderophore and has a novel mechanism of action which penetrates the outer cell membrane of Gram-negative pathogens.

Investigators in Italy found ceftolozane/tazobactam to be an effective treatment for some patients with severe ESBL-E infections.

Whole genome sequencing revealed little overlap between MDROs found in pets and pet owners.

A new report finds positive trends in most categories of multidrug-resistant bacterial infections; however, the pathogens still cause more than half a million infections each year.

Oral third-generation cephalosporins failed to treat Shigella sonnei infections despite in vitro susceptibility in 4 cases.

Use of prolonged IV antibiotics to treat infective endocarditis is outdated, and oral step-down therapy has been shown to be at least as effective.

IDSA reached its goal, but nobody’s buying. Can the drowning antimicrobial pipeline be saved?

In a new study, 38% of inpatients with bacteremia at an academic medical center had low procalcitonin values.

The CRACKLE-2 study examined clinical characteristics of 3 CRE subsets in the US.

A study evaluated whether frequent antibiotic use is associated with reduced infection related hospital admissions.

Growing evidence suggests that antimicrobials also interact with host innate immunity to provide potent indirect effects which enhance bacterial clearance and may result in more rapid and complete effects

Investigators in Rochester, NY, detailed the emergence of 3 antibiotic-resistant strains of Streptococcus pneumoniae since the introduction of the 13-valent pneumococcal conjugate vaccine in 2010.